Marrow capping agent for live marrow preservation and treatment and preparation method thereof
By combining carbon dot nanoenzyme with methacrylylated gelatin, C-NZ/GelMA composite hydrogel was developed, which solved the limitations of pulp preservation therapeutic materials in pulp regeneration and inflammation regulation, and achieved pulp tissue Effective repair and regeneration demonstrate good biocompatibility and mechanical properties.
Patent Information
- Application Number
- CN202411019533.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-29
- Publication Date
- 2024-11-01
AI Technical Summary
Existing pulp preservation therapeutic materials have limitations in pulp regeneration and inflammatory regulation, especially the non-degradable properties of calcium silicate hydromentin hinder pulp regeneration and lack targeting for pulp regeneration and inflammatory regulation.
A C-NZ/GelMA composite hydrogel was developed to form an antioxidant and immunomodulatory nanoenzymes with antioxidant and immunomodulatory functions by combining carbon dot nanoenzymes (C-NZ) with methacrylylated gelatin (GelMA). System, used for treatment of pulpitis, promotes repair and regeneration of pulp tissue.
C-NZ/GelMA composite hydrogel removes harmful oxidative stress substances in and out of the body, protects pulp cells, downregulates proinflammatory cytokines, upregulates anti-inflammatory cytokines, promotes dentin repair and regeneration of pulp tissue, and shows good results. The biocompatibility, mechanical properties and sustained release ability are suitable for the treatment of pulpitis.
Smart Images

Figure CN118873418A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of oral biomedical materials, and in particular to a pulp capping agent for vital pulp preservation and treatment and a preparation method thereof. Background Art
[0002] Due to the influence of factors such as caries and trauma, the dental pulp surrounded by hard tissue is exposed to bacteria, physical and chemical stimulation, which will trigger an inflammatory response. If the inflammatory response is not controlled, it is likely to gradually involve the entire pulp tissue, leading to progressive pulpitis, death of odontoblasts and ultimately pulp necrosis. Root canal therapy is currently the main treatment for pulpitis. It is a complex, expensive and destructive technology. Although it preserves the hard tissue of the tooth, it eliminates the inherent biological properties of the pulp, including perception, immunity, repair and nutrition functions, and increases the chance of tooth fracture and tooth loss. It has been reported that by eliminating damage, infection and placing appropriate pulp capping materials to control inflammation, the dentin-to-pulp complex can be repaired and regenerated. Vital pulp therapy (VPT) aims to preserve the vitality and function of the pulp tissue with minimal treatment intervention. It has been recommended by the American Association of Endodontists and the European Association of Endodontists for the treatment of reversible pulpitis, and has even achieved a high success rate in the treatment of irreversible pulpitis. Vital pulp preservation therapy (VPT) usually includes indirect or direct pulp capping, partial or complete pulpotomy. Calcium silicate cements (CSC) are increasingly used in the treatment of vital pulp preservation therapy (VPT). When CSC is in direct contact with pulp tissue, it can stimulate the material-pulp interface to form reparative dentin, prevent further damage to the pulp by external stimuli, and protect the remaining pulp tissue. However, due to the non-degradable nature of CSC, the regenerative potential of the pulp is hindered, especially the pulp tissue lost during pulpotomy cannot be restored. The ideal pulp capping material should not only maintain the vitality of the residual pulp, but also promote pulp tissue regeneration as part of the tissue engineering strategy to replace the lost pulp tissue and restore its normal structure and function. In addition, the current pulp capping materials are unsatisfactory in terms of the quality of reparative dentin formation, anti-inflammatory and antibacterial properties, and lack therapeutic targeting because they are not designed directly for pulp regeneration, pulp inflammation, or immunomodulatory processes. Therefore, there is an urgent need to develop a new generation of pulp capping biomaterials to overcome the limitations of existing materials.
[0003] The dental pulp microenvironment largely limits the efficacy of vital pulp preservation therapy (VPT). In the dental pulp microenvironment, inflammation and oxidative stress coexist and promote each other. If they cannot be effectively controlled, it will lead to the failure of vital pulp preservation therapy (VPT). In fact, pulp regeneration and dentin repair is a multi-step complex biological process, which is greatly affected by the oxidative stress microenvironment. Excessive production of reactive oxygen and nitrogen species (RONS) in the inflammatory environment can lead to cell protein damage, lipid peroxidation and DNA damage, cell function loss, proliferation inhibition and induction of cell apoptosis. At the same time, macrophages, as innate immune effector cells in the dental pulp, play a vital role in both inflammation and healing. The increase of reactive oxygen and nitrogen species (RONS) in macrophages and the accompanying oxidative stress state can induce a cascade of inflammatory reactions, trigger downstream inflammatory signals, and then affect the polarization state of macrophages and the secretion of inflammatory factors, ultimately affecting tissue repair and regeneration. Therefore, designing an antioxidant system to regulate the oxidative stress microenvironment of pulpitis may be an effective strategy for vital pulp preservation therapy to promote pulp tissue repair and regeneration.
[0004] Previous studies have explored the potential of a range of substances in regulating the oxidative stress environment of dental pulp, including antioxidants, small molecule inhibitors and bioactive materials. However, there is still room for improvement in the stability, accessibility and therapeutic effect of drugs, and more effective antioxidant systems remain to be explored and studied. Nanozymes are a class of nanomaterials that can catalyze enzyme substrates under mild or extreme conditions. They have the advantages of high catalytic activity, mild reaction conditions, good stability, low cost and easy large-scale production, and are promising alternatives to natural enzymes. Nanozymes have excellent catalytic properties and selectivity, and have made remarkable progress in biomedical applications. In the past few years, nanomaterials with the activity of mimicking catalase (CAT), superoxide dismutase (SOD) and glutathione peroxidase (GPx) have been used as antioxidant nanozymes to perform various types of antioxidant treatments by regulating the redox environment, such as nerve injury, diabetic wound healing, osteoarthritis, enteritis, periodontitis, etc. Studies on metal nanozymes regulating the redox balance of dental pulp stem cells have shown their potential in the treatment of pulpitis. However, nanozymes with both antioxidant and immunomodulatory functions are very important for the treatment of pulpitis. At present, it is still a challenge to design a multifunctional nanozyme antioxidant system for pulpitis immunomodulation. In addition, the in vivo toxicity of metal and metal oxide nanozymes during treatment is still an obstacle to clinical application, such as cytotoxicity and heavy metal accumulation. Carbon dot nanozymes (C-NZ) have ultrafast electron transfer speed and super catalytic activity, and their core structure is similar to graphene. Studies have shown that carbon dot nanozymes (C-NZ) can alleviate acute brain injury by reducing harmful reactive oxygen and reactive nitrogen (RONS). However, its application in the treatment of pulpitis remains to be explored.
[0005] Gelatin methacryloyl (GelMA) is considered to be a new generation of multifunctional platform for tissue engineering treatment due to its excellent biological properties and controllable physical properties. At present, there is no antioxidant system constructed by combining carbon dot nanozyme (C-NZ) with methacryloyl gelatin (GelMA). The present invention combines carbon dot nanozyme (C-NZ) with methacryloyl gelatin (GelMA) to construct a C-NZ / GelMA composite hydrogel antioxidant system for the treatment of pulpitis to achieve the effect of promoting pulp regeneration and restorative dentin formation. Summary of the invention
[0006] In view of the above shortcomings, the present invention provides a pulp capping agent for pulp preservation and treatment and a preparation method thereof, and develops a new effective pulp capping material that can promote the repair and regeneration of dental pulp tissue. The specific technical scheme is as follows:
[0007] A pulp capping agent for vital pulp preservation treatment, wherein the pulp capping agent is a C-NZ / GelMA composite hydrogel made of methacrylated gelatin GelMA carrying carbon dot nanozyme C-NZ.
[0008] The present invention also provides a method for preparing the vital pulp preservation treatment pulp capping agent as claimed in claim 1, comprising the following steps:
[0009] (1) Preparation of carbon dot nanozyme C-NZ:
[0010] a. Weigh o-phenylenediamine and dissolve it in anhydrous ethanol, and stir at room temperature to form a colorless transparent solution;
[0011] b. The colorless transparent solution was transferred to a stainless steel autoclave and reacted in an oven to obtain a dark brown solution;
[0012] c. After removing the residual ethanol in the dark brown solution, resuspend it with pure water and perform ultrasonic dispersion;
[0013] d. The dark brown solution after ultrasonic dispersion was centrifuged and filtered to collect the lower brown-yellow clear liquid, and then dialyzed in water with a dialysis bag, and the yellow liquid in the dialysis bag was collected and freeze-dried into powder to obtain the carbon dot nanozyme C-NZ, and the carbon dot nanozyme C-NZ was prepared into a solution for standby use;
[0014] (2) Preparation of photoinitiator standard solution: Accurately weigh the photoinitiator LAP powder and add it to the PBS solution, heat it in a light-proof water bath to dissolve it, and prepare the photoinitiator standard solution; photoinitiator LAP: lithium phenyl (2,4,6-trimethylbenzoyl) phosphinate (Lithium Phenyl (2,4,6-trimethylbenzoyl) phosphinate, LAP); PBS solution is a phosphate buffer solution;
[0015] (3) Preparation of C-NZ / GelMA composite hydrogel: Weigh freeze-dried methacryloyl gelatin GelMA and add it to the photoinitiator standard solution, heat it in a water bath under light-proof conditions, and oscillate it repeatedly several times. After heating, filter and sterilize the methacryloyl gelatin GelMA solution, then add the carbon dot nanozyme C-NZ solution and mix well in the dark to obtain the C-NZ / GelMA composite hydrogel.
[0016] Preferably, in step (1), the stainless steel high-pressure reactor is a reactor lined with polytetrafluoroethylene.
[0017] Preferably, in step (1), the oven reaction temperature is 150-200° C., and the reaction time is 1-2 h.
[0018] Preferably, in step (1), the method for removing the residual ethanol is rotary evaporation.
[0019] Preferably, in step (1), the centrifugation is performed using a 3KD ultrafiltration tube.
[0020] Preferably, in step (1), the molecular weight cutoff range of the dialysis bag is 100-500D.
[0021] Preferably, in step (2), the concentration of the photoinitiator standard solution is 0.1-0.3% (w / v).
[0022] Preferably, in step (3), the amino substitution degree of the methacrylylated gelatin GelMA is 50-70%.
[0023] Preferably, in step (3), the filtration sterilization is to filter the methacrylated gelatin GelMA solution in a clean bench using a 0.22 μm filter membrane for sterilization.
[0024] Compared with the prior art, the present invention has the following beneficial effects:
[0025] 1. The present invention synthesized a carbon dot nanozyme C-NZ with SOD- and GPx-enzyme mimicking activity, which has excellent antioxidant capacity, and used the tissue engineering scaffold material GelMA hydrogel to carry the carbon dot nanozyme C-NZ to prepare C-NZ / GelMA composite hydrogel, which was used as a pulp capping material for pulpitis VPT. C-NZ / GelMA composite hydrogel can protect dental pulp cells from oxidative stress damage in an inflammatory environment by removing harmful RONS in vivo and in vitro, downregulating the level of pro-inflammatory cytokines, and upregulating the level of anti-inflammatory cytokines.
[0026] 2. The C-NZ / GelMA composite hydrogel of the present invention has good biocompatibility, suitable mechanical properties, degradation rate and sustained release ability, which meet the main requirements of pulp capping materials. Through observation of the VPT model of rat molar pulpitis, it was found that direct pulp capping treatment with C-NZ / GelMA composite hydrogel can not only form reparative dentin with regular dentinal tubules, but also regenerate vascularized new pulp tissue, and promote the repair and regeneration of the pulp-dentin complex and pulp tissue under an inflammatory environment. In general, C-NZ / GelMA composite hydrogel is a very promising and effective pulp capping material for treating pulpitis and promoting the repair and regeneration of pulp tissue. BRIEF DESCRIPTION OF THE DRAWINGS
[0027] In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the drawings required for describing the embodiments are briefly introduced below.
[0028] Figure 1The graph shows the changes in the expression levels of pro-inflammatory cytokines (TNF-α, IL-6) and anti-inflammatory cytokines (IL-10) in the pulp tissue of maxillary incisors of rats;
[0029] Figure 2 H&E staining of maxillary molar tooth tissue of rats; the right image of each group is a partial enlargement of the black frame of the left image of the group;
[0030] Figure 3 The macroscopic and microscopic images of GelMA hydrogel and C-NZ / GelMA composite hydrogel of the present invention are shown; wherein, (A) macroscopic image of GelMA hydrogel; (B) macroscopic image of C-NZ / GelMA composite hydrogel; (C) SEM image of GelMA hydrogel; (D) SEM image of C-NZ / GelMA composite hydrogel;
[0031] Figure 4 The graphs for detecting the gelling ability of the C-NZ / GelMA composite hydrogel of the present invention; wherein, (A) images of the C-NZ / GelMA hydrogel before and after cross-linking; (B) rheological detection of the C-NZ / GelMA composite hydrogel;
[0032] Figure 5 This is a screenshot of the video for testing the injectability of the C-NZ / GelMA composite hydrogel of the present invention;
[0033] Figure 6 The mechanical properties test diagram of the hydrogel of the present invention; wherein, (A) stress-strain curve; (B) quantitative analysis of compression modulus;
[0034] Figure 7 is the swelling ratio of GelMA and the C-NZ / GelMA composite hydrogel of the present invention;
[0035] Figure 8 This is a graph showing the sustained release ability of the C-NZ / GelMA composite hydrogel of the present invention;
[0036] Fig. 9 This is the in vitro degradation curve of the C-NZ / GelMA composite hydrogel of the present invention;
[0037] Fig.10 The in vivo degradation detection diagram of the C-NZ / GelMA composite hydrogel of the present invention; wherein, (A) the fluorescence decay curve of the C-NZ / GelMA hydrogel; (B) the change of the fluorescence signal of the C-NZ / GelMA composite hydrogel in the dorsal area over time; (C) the dorsal hydrogel image of the mouse under bright field;
[0038] Fig.11Figure 1 is a diagram for evaluating the in vivo biocompatibility of the C-NZ / GelMA composite hydrogel of the present invention; wherein (A) images of the C-NZ / GelMA composite hydrogel implanted in the dorsal side of mice at different time points; (B) HE staining of the C-NZ / GelMA composite hydrogel and its surrounding tissues, with the right image being a magnified image of the part within the red frame; (C) HE staining of the main organs of mice implanted with the C-NZ / GelMA hydrogel for 35 days. DETAILED DESCRIPTION
[0039] The specific embodiments of the present invention are described in detail below, but it should be understood that the protection scope of the present invention is not limited by the specific embodiments.
[0040] Example 1
[0041] 1. Preparation of C-NZ
[0042] The specific synthesis steps are as follows:
[0043] (1) Weigh 1 g of o-phenylenediamine and dissolve it in 100 mL of anhydrous ethanol. Stir at room temperature to form a colorless transparent solution.
[0044] (2) The colorless transparent solution was transferred to a polytetrafluoroethylene-lined stainless steel autoclave and reacted in an oven at 180° C. for 1 h to obtain a dark brown solution.
[0045] (3) Use rotary evaporation to remove residual ethanol, then resuspend in 50 ml of pure water and disperse by ultrasonication for 10 min.
[0046] (4) The resuspended dark brown solution was centrifuged through a 3KD ultrafiltration tube, and the brown-yellow clear liquid at the bottom was collected by separation and filtration. It was then dialyzed in water for 1 hour using a 100D dialysis bag. Finally, the yellow liquid in the dialysis bag was collected and freeze-dried into powder as the final purified product.
[0047] 2. Preparation of C-NZ / GelMA composite hydrogel
[0048] (1) Preparation of 0.25% (w / v) lithium phenyl (2,4,6-trimethylbenzoyl) phosphinate (LAP) photoinitiator standard solution: Accurately weigh 50 mg of LAP powder and add it to 20 ml of PBS solution. Heat in a light-proof water bath at 40°C to dissolve the solution to obtain a 0.25% (w / v) LAP standard solution.
[0049] (2) Use GelMA hydrogel with 60% amino substitution degree to prepare C-NZ / GelMA composite hydrogels of different concentrations. Prepare C-NZ / GelMA composite hydrogels of different concentrations according to the ratio in Table 1. Specifically, weigh 50 mg of freeze-dried GelMA and add different volumes of 0.25% (w / v) LAP photoinitiator, heat in a 60°C water bath for 30 minutes in the dark, and oscillate repeatedly several times during the period. Then filter the GelMA solution using a 0.22μm filter membrane in an ultra-clean workbench for sterilization. Finally, add different volumes of C-NZ solution (100μM), mix in the dark, and prepare 10μM, 20μM, 30μM C-NZ / GelMA composite hydrogels and 5% (w / v) GelMA hydrogels respectively.
[0050] Table 1 Overview of C-NZ / GelMA samples with different concentrations and component ratios
[0051]
[0052]
[0053] Example 2
[0054] 1. Preparation of C-NZ
[0055] The specific synthesis steps are as follows:
[0056] (1) Weigh 1 g of o-phenylenediamine and dissolve it in 100 mL of anhydrous ethanol. Stir at room temperature to form a colorless transparent solution.
[0057] (2) The colorless transparent solution was transferred to a polytetrafluoroethylene-lined stainless steel autoclave and reacted in an oven at 150°C for 2 h to obtain a dark brown solution.
[0058] (3) Use rotary evaporation to remove residual ethanol, then resuspend in 50 ml of pure water and disperse by ultrasonication for 10 min.
[0059] (4) The resuspended dark brown solution was centrifuged through a 3KD ultrafiltration tube, and the brown-yellow clear liquid at the bottom was collected by separation and filtration. It was then dialyzed in water for 1 hour using a 500D dialysis bag. Finally, the yellow liquid in the dialysis bag was collected and freeze-dried into powder as the final purified product.
[0060] 2. Preparation of C-NZ / GelMA composite hydrogel
[0061] (1) Preparation of 0.15% (w / v) lithium phenyl (2,4,6-trimethylbenzoyl) phosphinate (LAP) photoinitiator standard solution: Accurately weigh 30 mg of LAP powder and add it to 20 ml of PBS solution. Heat in a light-proof water bath at 50°C to dissolve the solution to obtain a 0.1% (w / v) LAP standard solution.
[0062] (2) Use GelMA hydrogel with 70% amino substitution to prepare C-NZ / GelMA composite hydrogels of different concentrations. Prepare C-NZ / GelMA composite hydrogels of different concentrations according to the ratio in Table 1. Specifically, weigh 50 mg of freeze-dried GelMA and add different volumes of 0.15% (w / v) LAP photoinitiator, heat in a 70°C water bath for 30 minutes in the dark, and oscillate repeatedly several times during the period. Then filter the GelMA solution using a 0.22μm filter membrane in an ultra-clean workbench for sterilization. Finally, add different volumes of C-NZ solution (100μM) and mix in the dark to prepare 10μM, 20μM, 30μM C-NZ / GelMA composite hydrogels and 5% (w / v) GelMA hydrogels.
[0063] 1. Experimental study on the effect of C-NZ / GelMA composite hydrogel in treating pulpitis in rats
[0064] 1.1 Establishment of animal experimental model
[0065] 1.1.1 Selection of experimental animals and ethical review
[0066] The SD rats used in the experiment were purchased from the Experimental Animal Center of Guangxi Medical University. A total of 30 6-8 week old male SD rats were used in this experiment. All experimental procedures were carried out in accordance with the guidelines established by the Animal Research Ethics Committee of Guangxi Medical University (Animal Ethics Review Approval Number: 202307435). SD rats were raised under standard conditions of 23℃-25℃, with a light / dark cycle of 12h, and sufficient water and pelleted feed were provided for rats to eat freely according to animal husbandry standards.
[0067] 1.1.2 Experimental Animal Grouping
[0068] Rats were divided into 4 groups according to treatment:
[0069] (1) Control group: no treatment was performed on the teeth; (2) Pulpitis group: only Pg-LPS was used to construct the pulpitis model without treatment; (3) Pulpitis+GelMA group: the pulpitis model was constructed using Pg-LPS, and the GelMA hydrogel prepared in Example 1 was used for pulp capping treatment; (4) Pulpitis+C-NZ / GelMA group: the pulpitis model was constructed using Pg-LPS, and the C-NZ / GelMA composite hydrogel prepared in Example 1 was used for pulp capping treatment.
[0070] 2. Evaluation of the effect of C-NZ / GelMA in treating pulpitis in rats
[0071] 2.1 Evaluation of inflammatory cytokine levels in the pulp tissue of maxillary incisors in rats
[0072] Due to the close relationship between oxidative stress and inflammation, the study tracked the changes in the expression levels of pro-inflammatory cytokines (TNF-α, IL-6) and anti-inflammatory cytokines (IL-10) in the pulp tissue of rat maxillary incisors. Figure 1 ).
[0073] The results of ELISA experiments showed that the expression levels of proinflammatory cytokines (TNF-α, IL-6) in pulp tissue of pulpitis group were significantly higher than those of control group. On the 3rd day after pulp capping, there was no statistical difference in the expression levels of TNF-α and IL-6 in Pulpitis+GelMA group compared with Pulpitis group, and the expression level of proinflammatory factors in Pulpitis+C-NZ / GelMA group was significantly decreased. On the 7th day after surgery, the expression level of TNF-α in Pulpitis+GelMA group was decreased, and the expression level of IL-6 was not statistically different from that in Pulpitis group; the expression levels of proinflammatory factors in Pulpitis+C-NZ / GelMA group were significantly decreased, and there was no statistical difference compared with the Control group.
[0074] The expression level of the anti-inflammatory cytokine IL-10 was detected, and it was found that the IL-10 concentrations of the other three groups were significantly increased compared with the Control group. However, the IL-10 content of the Pulpitis+C-NZ / GelMA group was the highest on the 3rd day and then declined on the 7th day.
[0075] The above results prove that Pg-LPS can fully stimulate the immune response in dental pulp tissue, and the expression of anti-inflammatory and pro-inflammatory cytokines is significantly increased. C-NZ / GelMA composite hydrogel can effectively downregulate the expression of pro-inflammatory cytokines TNF-α and IL-6.
[0076] 2.2 HE staining results of rat molar tooth tissue
[0077] Histological analysis of the maxillary first molars of rats was performed to evaluate the grade of inflammation and mineralization in the pulp tissue and to observe the formation of reparative dentin and vascularization. Figure 2 ) observed that two days after Pg-LPS stimulation, a cell-free tissue necrosis area appeared under the paper twist, and adjacent to the necrosis area was a dense inflammatory cell infiltration area, which was confined to the pulp tissue near the injured site. Three days after treatment with the two groups of hydrogels, an increase in the range of inflammatory infiltration was observed, and necrotic areas were interspersed in the inflammatory infiltration area. On the 7th day after treatment, the range of inflammation in both treatment groups was significantly reduced and confined to the pulp-material interface. It is very interesting that in the Pulpitis+C-NZ / GelMA group, a thick layer of multi-cellular layers with a uniform matrix structure and scattered small blood vessels appeared in the pulp tissue adjacent to the inflammatory infiltration area, suggesting that the inflammatory pulp tissue has entered the repair and proliferation stage, and the new pulp tissue has gradually replaced the necrotic tissue.
[0078] On the 35th day, the treatment of pulpitis in rat molars in the Pulpitis+C-NZ / GelMA group and the Pulpitis+GelMA group showed different outcomes. H&E staining showed that the area where the C-NZ / GelMA composite hydrogel was located in the Pulpitis+C-NZ / GelMA group was replaced by a new pulp-dentin complex. The new reparative dentin was close to the primary dentin, or surrounded the dentin debris, with regularly arranged dentinal tubules; the odontoblast-like cell layer was neatly arranged under the reparative dentin, and no ectopic mineralized tissue was observed. It is worth noting that new pulp tissue with a large number of blood vessels can be observed, which indicates that C-NZ / GelMA promotes higher quality tissue regeneration rather than just a repair response in the context of pulp inflammation. The area where the GelMA hydrogel was located in the Pulpitis+GelMA group was filled with necrotic tissue without cell structure, and the pulp adjacent to the injured site was replaced by disordered calcified tissue and fibrous connective tissue lacking cell structure; inflammatory cells infiltrated around the calcified tissue.
[0079] 3. Physical and chemical properties of C-NZ / GelMA composite hydrogel
[0080] 3.1 Macroscopic and microscopic morphology observation of C-NZ / GelMA composite hydrogel
[0081] The five-pointed star-shaped GelMA hydrogel and C-NZ / GelMA composite hydrogel ( Figure 3 A and Figure 3B). During the production process, it was found that the GelMA hydrogel and C-NZ / GelMA composite hydrogel before curing had good fluidity and could quickly conform to the sharp angles of the five-pointed star. After curing with a UV light source, the GelMA hydrogel and C-NZ / GelMA composite hydrogel appeared jelly-like with a certain viscosity on the surface. After adding C-NZ nanoparticles to the GelMA hydrogel, the color of the hydrogel changed from transparent to yellow. After carefully separating the hydrogel from the mold with a pin, it was found that the GelMA hydrogel and C-NZ / GelMA composite hydrogel could maintain the five-pointed star shape for a long time, indicating that both the GelMA hydrogel and the C-NZ / GelMA composite hydrogel have good formability and certain mechanical strength.
[0082] The microscopic morphology of the cross-section of GelMA hydrogel and C-NZ / GelMA composite hydrogel was observed by scanning electron microscopy. It was found that both GelMA hydrogel and C-NZ / GelMA composite hydrogel had uniformly distributed and interconnected pore structures. In addition, the pore and structure size of C-NZ / GelMA composite hydrogel were similar to that of GelMA hydrogel ( Figure 3 C and Figure 3 D). The difference is that the pore surface of GelMA hydrogel is smooth, while the surface of C-NZ / GelMA composite hydrogel has evenly distributed C-NZ nanoparticles and the surface of C-NZ / GelMA composite hydrogel is frosted.
[0083] 3.2 Rheological test of C-NZ / GelMA composite hydrogel
[0084] First, the photocrosslinking ability of C-NZ / GelMA composite hydrogel was visually observed through sol-gel conversion experiments. Figure 4 As shown in A, the C-NZ / GelMA composite hydrogel is a yellow clear liquid before photo-crosslinking. After irradiation with a 405 nm ultraviolet light source for 30 seconds, the C-NZ / GelMA composite hydrogel coagulates into a gel and loses fluidity.
[0085] At the same time, the rheological test of the photosensitivity of C-NZ / GelMA composite hydrogel also showed that C-NZ / GelMA composite hydrogel can be rapidly crosslinked within a relatively short safe exposure time (30s). Figure 4B). Shear storage modulus (G') and shear loss modulus (G") are two main rheological parameters that define the solid-like and fluid-like behaviors of hydrogels, respectively. Before photocrosslinking, G' and G" were both at low values, indicating that the C-NZ / GelMA composite hydrogel had good fluidity before photocrosslinking. During the photocrosslinking process, both G' and G" increased significantly, and the degree of increase in G' was significantly higher than that of G", and remained stable after crosslinking was completed, indicating that the photocrosslinking process stimulated the transformation of the C-NZ / GelMA composite hydrogel from sol to gel, and it has a stable crosslinking structure and maintains stable formability.
[0086] 3.3 Test of injectable properties of C-NZ / GelMA composite hydrogel
[0087] C-NZ / GelMA composite hydrogels are similar to GelMA hydrogels and have very good fluidity before photocrosslinking ( Figure 5 ). In an environment of 36-37°C, the C-NZ / GelMA composite hydrogel is in liquid form and can be easily extracted using a 1ml syringe and injected into the slit quartz cuvette through a root canal irrigation needle. Because the C-NZ carbon dot nanozyme has stable fluorescence properties, the C-NZ / GelMA composite hydrogel can be observed as yellow fluorescent droplets dripping into the slit under a 365nm ultraviolet light environment, which conforms to its narrow and long shape. The slit has a certain similarity to the morphology of the root canal, which shows that the C-NZ / GelMA composite hydrogel has the ability to adapt to the complex morphology of the root canal during in vivo use.
[0088] 3.4 Mechanical properties of C-NZ / GelMA composite hydrogels
[0089] The mechanical properties of C-NZ / GelMA composite hydrogel were evaluated by stress-strain curves and compression modulus. Figure 6 A shows the stress-strain curves of the two hydrogels under compression mode. The C-NZ / GelMA composite hydrogel has a similar stress-strain curve to the GelMA hydrogel. When the pressure is less than 20 Kpa, the C-NZ / GelMA composite hydrogel does not undergo obvious elastic deformation; when the pressure is greater than 50 Kpa, the C-NZ / GelMA composite hydrogel begins to undergo obvious elastic deformation as the pressure increases; when the pressure reaches 120 Kpa, the C-NZ / GelMA composite hydrogel still does not break.
[0090] After analysis, the compression modulus of C-NZ / GelMA composite hydrogel and GelMA hydrogel were both 10Kpa ( Figure 6B). When the addition amount of C-NZ nanoparticles was 10 μM, the addition of C-NZ nanoparticles did not significantly change the mechanical properties of GelMA. This may be related to the small amount of C-NZ added. The above experimental results show that the C-NZ / GelMA composite hydrogel has suitable mechanical strength and elasticity to support the upper restoration.
[0091] 3.5Swelling property test of C-NZ / GelMA composite hydrogel
[0092] Next, the swelling kinetics of C-NZ / GelMA composite hydrogels and GelMA hydrogels were evaluated. Figure 7 As shown in the figure, the C-NZ / GelMA composite hydrogel and GelMA hydrogel prepared in the experiment contain abundant water. Compared with the initial freeze-dried weight of the hydrogel, the weight of the GelMA hydrogel increased by more than 1400%, while the weight of the C-NZ / GelMA composite hydrogel increased by nearly 1500%. This is related to the three-dimensional network structure and hydrophilicity of the hydrogel. The freeze-dried C-NZ / GelMA composite hydrogel and GelMA hydrogel have abundant pores, and the abundant hydroxyl groups on the main chain give them good hydrophilicity, which makes the C-NZ / GelMA composite hydrogel and GelMA hydrogel have excellent water storage capacity. The prepared C-NZ / GelMA composite hydrogel and GelMA hydrogel were immersed in PBS (pH = 7.4) at 37°C to further observe their swelling properties. The C-NZ / GelMA composite hydrogel reached swelling equilibrium in about 12 hours, and the swelling rate increased by about 265%. The GelMA hydrogel reached swelling equilibrium in about 24 hours, and the swelling rate increased by about 393%.
[0093] 3.6 Detection of sustained release ability of C-NZ / GelMA composite hydrogel
[0094] Sustained release capacity is an important parameter for observing the biological application performance of materials. It describes the ability of nanoparticles to be gradually released from the hydrogel cross-linking system over time to achieve biological functions. According to the release curve of C-NZ / GelMA composite hydrogel ( Figure 8 ), about 15% of the C-NZ nanoparticles were released within 36 hours, and then entered a slow and uniform release state, with a release period of up to 28 days.
[0095] 3.7 In vitro degradation performance test of C-NZ / GelMA composite hydrogel
[0096] In vitro degradation experiments were conducted to evaluate the degradation of C-NZ / GelMA composite hydrogels in 2U collagenase II PBS solution ( Fig. 9). Due to the enzymatic degradation characteristics of the main chain structure of C-NZ / GelMA composite hydrogel and GelMA hydrogel, rapid degradation of the hydrogel was observed in the presence of collagenase, and there was no significant difference in the degradation rate of the two hydrogels. Specifically, about 60% of the hydrogel was degraded within two hours, and the hydrogel was completely degraded in 8 hours.
[0097] 3.8 In vivo degradation performance testing of C-NZ / GelMA composite hydrogel
[0098] Although the C-NZ / GelMA composite hydrogel was observed to degrade rapidly under the action of collagenase in the in vitro experiment, considering the more complex tissue environment in the body, in order to further observe the degradation of the C-NZ / GelMA composite hydrogel in vivo, the C-NZ / GelMA composite hydrogel was implanted in the back of mice for research. The degradation of the C-NZ / GelMA composite hydrogel in mice was evaluated by direct observation and the change of the fluorescence signal of the C-NZ / GelMA hydrogel in the subcutaneous tissue over time ( Fig.10 ).
[0099] The degradation of C-NZ / GelMA composite hydrogel on the back of mice at different time points was observed by the animal live imaging system. As time goes on, it can be seen that the volume of C-NZ / GelMA composite hydrogel continues to decrease, the area of fluorescence signal gradually decreases, the intensity gradually weakens, and the fluorescence signal is limited to the implantation area. This shows that C-NZ / GelMA composite hydrogel is constantly decomposed in the body, and C-NZ nanoparticles are gradually released. The released C-NZ nanoparticles do not accumulate locally. At the same time, quantitative analysis of the fluorescence attenuation of C-NZ / GelMA composite hydrogel shows that the degradation rate of C-NZ / GelMA composite hydrogel is relatively fast in the first 15 days, and the degradation of the hydrogel is basically complete on the 35th day.
[0100] Evaluation of in vivo biocompatibility of 3.9C-NZ / GelMA composite hydrogel
[0101] After the C-NZ / GelMA composite hydrogel was implanted under the skin of the mouse's back, it initially had good mobility. After 3 days, the C-NZ / GelMA composite hydrogel adhered to the surrounding tissues and its position was gradually fixed. After the C-NZ / GelMA composite hydrogel was implanted, no adverse reactions such as redness, swelling, erosion or damage to the surface skin and surrounding tissues were observed during the entire test period, indicating that the hydrogel has been well accepted by the host animal ( Fig.11A). H&E sections of C-NZ / GelMA composite hydrogel and its surrounding tissues showed that the implanted hydrogel was located in the subcutaneous connective tissue, tightly surrounded by a small number of fibroblasts, without inflammatory cell aggregation, and no abnormalities were found in the surrounding adipose tissue, muscle tissue, hair follicles, and sebaceous glands. Under a high-power microscope, macrophages with vacuoles were seen on the inner side of the fibrous connective tissue close to the hydrogel. The macrophages engulfed the hydrogel, making the edge of the hydrogel appear jagged ( Fig.11 B). Therefore, in addition to the enzymatic effect, the phagocytic effect of macrophages is also an important factor in the degradation of C-NZ / GelMA composite hydrogel in vivo. At the end of the experiment, histopathological examinations were performed on important organs such as the lungs, liver, spleen, kidneys, and heart, and no pathological changes such as degeneration, atrophy, and necrosis were observed ( Fig.11 C). These data fully demonstrate that the biodegradable C-NZ / GelMA composite hydrogel has a high biosafety in mice.
[0102] In summary, the C-NZ / GelMA composite hydrogel of the present invention has good biocompatibility, suitable mechanical properties, degradation rate and sustained release ability, which meet the main requirements of pulp capping materials. Through observation of the VPT model of rat molar pulpitis, it was found that direct pulp capping treatment with C-NZ / GelMA composite hydrogel can not only form reparative dentin with regular dentinal tubules, but also regenerate vascularized new pulp tissue, and promote the repair and regeneration of the pulp-dentin complex and pulp tissue under an inflammatory environment. In general, C-NZ / GelMA composite hydrogel is a very promising and effective pulp capping material for treating pulpitis and promoting the repair and regeneration of pulp tissue.
[0103] The foregoing description of specific exemplary embodiments of the present invention is for the purpose of illustration and demonstration. These descriptions are not intended to limit the present invention to the precise form disclosed, and it is clear that many changes and variations can be made based on the above teachings. The purpose of selecting and describing the exemplary embodiments is to explain the specific principles of the present invention and its practical application, so that those skilled in the art can realize and utilize various different exemplary embodiments of the present invention and various different selections and changes. The scope of the present invention is intended to be limited by the claims and their equivalents.
Claims
1. A pulp capping agent for vital pulp preservation treatment, characterized in that: The pulp capping agent is a C-NZ / GelMA composite hydrogel made of methacrylated gelatin GelMA and carbon dot nanozyme C-NZ.
2. A method for preparing the pulp capping agent for vital pulp preservation treatment as claimed in claim 1, characterized in that: The following steps are involved: (1) Preparation of carbon dot nanozyme C-NZ: a. Weigh o-phenylenediamine and dissolve it in anhydrous ethanol, and stir at room temperature to form a colorless transparent solution; b. The colorless transparent solution was transferred to a stainless steel autoclave and reacted in an oven to obtain a dark brown solution; c. After removing the residual ethanol in the dark brown solution, resuspend it with pure water and perform ultrasonic dispersion; d. The dark brown solution after ultrasonic dispersion was centrifuged and filtered to collect the lower brown-yellow clear liquid, and then dialyzed in water with a dialysis bag, and the yellow liquid in the dialysis bag was collected and freeze-dried into powder to obtain the carbon dot nanozyme C-NZ, and the carbon dot nanozyme C-NZ was prepared into a solution for standby use; (2) Preparation of photoinitiator standard solution: Accurately weigh the photoinitiator LAP powder and add it to the PBS solution, heat it in a dark water bath to dissolve it, and prepare the photoinitiator standard solution; (3) Preparation of C-NZ / GelMA composite hydrogel: Weigh freeze-dried methacryloyl gelatin GelMA and add it to the photoinitiator standard solution, heat it in a water bath under light-proof conditions, and oscillate it repeatedly several times. After heating, filter and sterilize the methacryloyl gelatin GelMA solution, then add the carbon dot nanozyme C-NZ solution and mix well in the dark to obtain the C-NZ / GelMA composite hydrogel.
3. The method for preparing a pulp capping agent for vital pulp preservation treatment according to claim 2, characterized in that: In step (1), the stainless steel high-pressure reactor is a reactor lined with polytetrafluoroethylene.
4. The method for preparing a pulp capping agent for vital pulp preservation treatment according to claim 2, characterized in that: In step (1), the oven reaction temperature is 150-200° C., and the reaction time is 1-2 h.
5. The method for preparing a pulp capping agent for vital pulp preservation treatment according to claim 2, characterized in that: In step (1), the method for removing the residual ethanol is rotary evaporation.
6. The method for preparing a pulp capping agent for vital pulp preservation treatment according to claim 2, characterized in that: In step (1), the centrifugation is performed using a 3KD ultrafiltration tube.
7. The method for preparing a pulp capping agent for vital pulp preservation treatment according to claim 2, characterized in that: In step (1), the molecular weight cutoff range of the dialysis bag is 100-500D.
8. The method for preparing a pulp capping agent for vital pulp preservation treatment according to claim 2, characterized in that: In step (2), the concentration of the photoinitiator standard solution is 0.1-0.3% (w / v).
9. The method for preparing a pulp capping agent for vital pulp preservation treatment according to claim 2, characterized in that: In step (3), the amino substitution degree of the methacrylylated gelatin GelMA is 50-70%.
10. The method for preparing a pulp capping agent for vital pulp preservation treatment according to claim 2, characterized in that: In step (3), the filtration sterilization is to filter and sterilize the methacrylylated gelatin GelMA solution using a 0.22 μm filter membrane in an ultra-clean workbench.
